Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

New England Journal of Medicine

Volumn 333, Issue 2, 1995, Pages 89-94

  Partanen, Juhani ^a   Niskanen, Leo ^b   Lehtinen, Juha ^a   Mervaala, Esa ^a   Siitonen, Onni ^b   Uusitupa, Matti ^b  

^a Clinical Neurophysiology   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; ELECTRODIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PAIN ASSESSMENT; PARESTHESIA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMAN; INSULIN; MALE; MIDDLE AGE; MOTOR NEURONS; NEURAL CONDUCTION; PERIPHERAL NERVES; PREVALENCE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0029038374     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199507133330203     Document Type: Article

References (20)

1. Pirart J Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-188
2. Lehtinen JM, Uusitupa M, Siitonen O, Pyorala K Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989; 38: 1307-1313
3. Lehtinen JM, Niskanen L, Hyvonen K, Siitonen O, Uusitupa M Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects -- a 5-year follow-up. Diabetologia 1993; 36: 68-72
4. Uusitupa M, Siitonen O, Aro A, Pyorala K Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1985; 28: 22-27
5. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser 1980; 646: 7-80
6. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-1184
7. Niskanen L, Karjalainen J, Siitonen O, Uusitupa M Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Intern Med 1994; 236: 263-270
8. Penttila IM, Voutilainen E, Laitinen P, Juutilainen P Comparison of different analytical and precipitation methods for the direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest 1981; 41: 353-360
9. Lehtinen J. Diabetic neuropathy in newly diagnosed non-insulin-dependent diabetics. (Ph.D. thesis. Kuopio, Finland: University of Kuopio, 1987.)
10. Lang AH, Forsstrom J, Bjorkqvist S-E, Kuusela V Statistical variation of nerve conduction velocity: an analysis of normal subjects and uraemic patients. J Neurol Sci 1977; 33: 229-241
11. Ratzmann KP, Raschke M, Gander I, Schimke E Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (non-insulin-dependent) diabetes. J Diabet Complications 1991; 5: 1-5
12. Mincu I Micro- and macroangiopathies and other chronic degenerative complications in newly detected diabetes mellitus. Med Interne Romania 1980; 18: 155-164
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
14. Harati Y Frequently asked questions about diabetic peripheral neuropathies. Neurol Clin 1992; 10: 783-807
15. Cameron NE, Cotter MA The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 1994; 10: 189-224
16. Scarpini E, Bianchi R, Moggio M, Sciacco M, Fiori MG, Scarlato G Decrease of nerve Na+, K+ -ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci 1993; 120: 159-167
17. Dyck PJ, Karnes JL, O'Brien P, The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19: 440-449
18. Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinicopathological study. Brain 1991; 114: 867-892
19. Niskanen LK, Uusitupa MI, Sarlund H, Siitonen O, Pyorala K Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Diabetes Care 1990; 13: 41-48
20. Wahren J, Johansson B.-L., Wallberg-Henriksson H Does C-peptide have a physiological role? Diabetologia 1994; 37: Suppl 2: S99-S107